Intco Medical Technology300677.SZValuation Analysis
Based on the blended 10-year P/E and P/B percentiles, the stock currently sits in the “Fair Value Range” zone.
As of Oct 19, 2026, Intco Medical Technology (300677.SZ) trades at a P/E of 24.90x, P/B of 1.50x, P/S of 2.05x, and a dividend yield of 0.34%.
Longitudinal percentile comparison: P/E sits at the 59th percentile over the trailing 10Y window (vs. 51st percentile over 3Y); P/B sits at the 40th percentile over the trailing 10Y window (vs. 71st percentile over 3Y); P/S sits at the 45th percentile over the trailing 10Y window (vs. 46th percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 30th percentile within its industry and the 34th percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 0.60%, ranking at the 39th percentile over the trailing 20Y window.
The P/E and P/B percentiles diverge here, differing by 19.4 points — relying on either metric alone could be misleading. Its P/E percentile is roughly the same whether measured against the industry or the broader market. Breaking down the total shareholder yield: 0.34% comes from cash dividends, with an implied ~0.26% from buybacks — a fairly balanced mix of both channels. Intco Medical Technology operates in the Medicine sector. Data refreshes weekly and is for reference only, not investment advice.
Also listed as: SHE: 300677 · SZSE: 300677 · 300677
Want the full picture on whether Intco Medical Technology (300677.SZ) is under- or over-valued? See the full 3Y / 5Y / 10Y / 20Y P/E, P/B, P/S, Dividend Yield & Total Shareholder Yield percentile matrix and the interactive ECharts trend chart on this page.
Historical Percentiles by Metric
| Metric | Current | Market Percentile | Industry Percentile | 3Y Pctl | 5Y Pctl | 10Y Pctl | 20Y Pctl |
|---|---|---|---|---|---|---|---|
| P/E (TTM) | 24.90 | ||||||
| P/B (MRQ) | 1.50 | ||||||
| P/S (TTM) | 2.05 | ||||||
| Dividend Yield | 0.34% | ||||||
| Buyback + Div Yield | 0.60% |